Michael Scolaro

Michael Scolaro

Sep 20, 2017

Group 6 Copy 618
-1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

The Health Justice Project: Using digital stories to address health disparities as a social justice issue

The purpose of this project is to examine the link between racial and social injustice based on one's minority...

Does Zika virus suppress the antiviral host response in neuronal cells?

Zika virus is spreading rapidly in the Western hemisphere and is linked to fetal microcephaly. We recently...

Can we Measure the Body's Response to Implants by Testing the Blood?

Would you or a loved one someday benefit from a life-saving medical implant? However, the organisms adapt...

Backer Badge Funded